Antonella Tripiciano

The Presence of Anti‐Tat Antibodies Is Predictive of Long‐Term Nonprogression to AIDS or Severe Immunodeficiency: Findings in a Cohort of HIV‐1 Seroconverters

Giovanni Rezza, Valeria Fiorelli, Maria Dorrucci et al. · The Journal of Infectious Diseases · 2005 · 110 citations · Full text

Hiv‐1 Seroconverters, Immunodeficiencies, Immunology +19

Therapeutic Immunization with HIV-1 Tat Reduces Immune Activation and Loss of Regulatory T-Cells and Improves Immune Function in Subjects on HAART

Barbara Ensoli, Stefania Bellino, Antonella Tripiciano et al. · PLoS ONE · 2010 · 93 citations · Full text

Long-term protection against SHIV89.6P replication in HIV-1 Tat vaccinated cynomolgus monkeys

Maria Teresa Maggiorella, Silvia Baroncelli, Zuleika Michelini et al. · Vaccine · 2004 · 78 citations · Full text

Vaccination, Viral Replication, Vaccine Development +11

Sequence Conservation and Antibody Cross‐Recognition of Clade B Human Immunodeficiency Virus (HIV) Type 1 Tat Protein in HIV‐1–Infected Italians, Ugandans, and South Africans

Stefano Buttò, Valeria Fiorelli, Antonella Tripiciano et al. · The Journal of Infectious Diseases · 2003 · 64 citations · Full text

Antibody Cross‐recognition, South Africans, Immunodeficiencies +19

Efficient mucosal delivery of the HIV‐1 Tat protein using the synthetic lipopeptide MALP‐2 as adjuvant

Stefan Borsutzky, Valeria Fiorelli, Thomas Ebensen et al. · European Journal of Immunology · 2003 · 62 citations